三鑫醫療(300453.SZ)擬增加經營範圍“消毒產品(危險化學品除外)”
格隆匯3月27日丨三鑫醫療(300453.SZ)公佈,根據公司經營與發展需要,公司經營範圍擬增加“消毒產品(危險化學品除外)”。變更後的經營範圍為:醫療器械的生產;醫療器械經營;消毒產品(危險化學品除外);經營本企業生產、科研所需的原輔材料、機械設備、儀器儀表、零配件及相關技術的進口業務及本企業的進料加工和“三來一補”業務、醫療設備租賃。(以上項目依法需經批准的項目,需經相關部門批准後方可開展經營活動)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.